Photograph of Alexis J. Gilman View LinkedIn page Download V-card

Alexis J. Gilman

Partner

agilman@crowell.com
Phone: +1 202.624.2570
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Alexis J. Gilman is a partner in Crowell & Moring’s Antitrust Group, who brings significant prior government experience to his work with clients. At Crowell, Alexis advises and represents clients on a broad range of civil antitrust and competition matters, including merger reviews and clearances, government investigations, premerger Hart-Scott-Rodino (HSR) notifications, and antitrust litigation, with a particular focus on representing merging parties and third parties in merger investigations by the Federal Trade Commission, Department of Justice, and state attorneys general offices. He also counsels businesses and trade associations on antitrust compliance. His experience spans a wide range of industries and includes deep experience in healthcare, retail, consumer goods, food and beverage, distribution, casinos and gaming, biotechnology, and energy. In 2019, based on research with clients and peers, Alexis was selected by Who’s Who Legal for recognition in the category Competition Future Leaders – Partners.

Since joining Crowell, select matters include:

  • Representing integrated healthcare system in connection with its affiliation with a larger healthcare system.
  • Representing a leading global manufacturer and marketer of branded consumer foods as a third party in an FTC merger investigation.
  • Representing a marketer and seller of consumer products as a third party in an FTC merger investigation.
  • Representing a multinational Fortune 20 healthcare services company as a third party in an FTC conduct investigation.
  • Representing a Fortune 100 healthcare services company as a third party in an FTC merger investigation.
  • Represented AT&T in its successful defense of the DOJ’s suit challenging its $85 billion acquisition of Time Warner.
  • Represented a grocery retailer as a third party in an FTC supermarket merger investigation.
  • Represented an office products distributor as a third party in an FTC office supplies merger investigation.
  • Counseling a national transportation-services provider and energy industry trade association on antitrust compliance issues.

Alexis joined the firm from the Federal Trade Commission, where he led a 30-attorney division and worked on some of the agency's highest-profile matters. From 2014-2017, Alexis served as the Assistant Director of the Mergers IV Division in the Bureau of Competition of the Federal Trade Commission, where he had leading roles in and oversaw investigations and litigation in various industries, including hospitals and other healthcare providers, distribution services, retail, consumer goods, food and beverage, supermarkets, funeral homes, casinos, and online gaming. Prior to this position, Alexis served as a Deputy Assistant Director of the Mergers IV Division from 2012-2014, and a Staff Attorney in the division from 2010-2012. While at the FTC, Alexis had leading roles on several high-profile merger investigations and litigation, including:

Healthcare

  • FTC and IL v. Advocate/NorthShore (preliminary injunction enjoining transaction)
  • FTC v. ProMedica/St. Luke's (injunction ordering unwinding of transaction upheld by the Sixth Circuit, cert. denied)
  • In re Cabell/St. Mary’s (complaint filed, later withdrawn after state approved merger under cooperative agreement)
  • FTC v. Phoebe Putney/Palmyra (merger consummated subject to consent order)
  • Mountain States/Wellmont Health System (merger consummated under COPA and cooperative agreement)
  • CHS/HMA (consent order requiring two hospital divestitures)
  • UHS/Ascend (consent order requiring divestiture)

Retail/Consumer Goods

  • Amazon/Whole Foods
  • Dollar Tree/Family Dollar (consent order requiring divestiture of 330 stores)
  • Albertsons/Safeway (consent order requiring divestiture of 168 supermarkets)
  • Office Depot/OfficeMax
  • Men's Wearhouse/Jos. A. Bank
  • Bass Pro/Cabela's
  • Ahold/Delhaize (consent order requiring divestiture of 81 supermarkets)

Distribution, Casinos, Gaming, and Other 

  • FTC v. Sysco/US Foods (preliminary injunction enjoining $8.2 billion transaction)
  • FTC v. Staples/Office Depot (preliminary injunction enjoining $6.3 billion transaction)
  • FTC v. DraftKings/FanDuel (complaint filed, transaction abandoned)
  • FTC v. Pinnacle/Ameristar (complaint filed, $2.8 billion merger closed subject to consent order requiring divestitures)
  • SCI/Stewart Enterprises ($1.4 billion merger consummated subject to consent order requiring divestitures in 59 markets)

Prior to joining the FTC, Alexis was an associate in the Antitrust Group of a large U.S.-based law firm, where he represented Fortune 500 companies in U.S. and foreign merger investigations and other civil antitrust matters. He represented pharmaceutical, publishing, retail, chemical, energy, and private equity clients, among others. Select matters included:

  • Pfizer in its $68 billion acquisition of Wyeth.
  • Perrigo in its $808 million acquisition of PBM Products.
  • Apollo Management in connection with its portfolio company's, Hexion Specialty Chemicals', acquisition of Akzo Nobel’s Inks and Adhesives Resins business.
  • Pearson in its $950 million acquisition of Harcourt Assessment and Harcourt Education International from Reed Elsevier.
  • Pharmacia in its $60 billion acquisition by Pfizer.

Alexis is a frequent speaker at ABA, American Health Lawyers Association, and other organization events. Alexis received his J.D. with honors from The George Washington University Law School where he was a member of the George Washington International Law Review. He received his B.A. from Williams College. He is originally from Maine.

Education

  • Williams College, B.A. (1996)
  • The George Washington University Law School, J.D. (2002)

Affiliations

Admitted to practice: District of Columbia, Massachusetts (inactive)

Professional Activities and Memberships

  • Member of the American Bar Association and its Antitrust, Litigation, and Business Law Sections
  • Member of The American Health Lawyers Association and its Antitrust, Business Law and Governance, and In-House Counsel Practice Groups
  • Member of the Hispanic National Bar Association

View More

"DOJ Approves Group Purchasing Activities that Fall Outside “Antitrust Safety Zone”," Antitrust Law Alert (February 13, 2020). Contacts: Lauren B. Patterson, Juan A. Arteaga, Alexis J. Gilman
Client Alert / Newsletter
"Merger Review Retrospective," GCR Live 9th Annual Antitrust Law Leaders Forum, Miami, FL (February 7, 2020). Moderator: Alexis J. Gilman.
Speech/Presentation
2019's Biggest Antitrust Developments and What to Expect in 2020 AHLA's Speaking of Health Law Podcast (February 6, 2020)
In the News
"Merging Parties Beware: DOJ Follows Through on Promise to Vigorously Enforce Merger Consent Decrees," Antitrust Law Alert (February 3, 2020). Contacts: Shawn R. Johnson, Juan A. Arteaga, Alexis J. Gilman
Client Alert / Newsletter
"Illumina/PacBio: Killing A Killer Acquisition, Or The Birth Of Nascent Competition Enforcement?," GCR (January 22, 2020). Authors: Alexis J. Gilman, Sean-Paul Brankin, Olivier N. Antoine, Evi Mattioli and Eric Ashby.
Publication
Killing A Killer Acquisition, Or The Birth Of Nascent Competition Enforcement? Global Competition Review (January 22, 2020)
In the News
FTC's Antitrust Powers Under Indirect Attack Law360 (January 21, 2020)
In the News
"FTC and DOJ Issue Draft of Long-Anticipated Vertical Merger Guidelines," Antitrust Law Alert (January 15, 2020). Contacts: Alexis J. Gilman, Shawn R. Johnson, Wm. Randolph Smith, Jeane A. Thomas, CIPP/E, Andrew I. Gavil, Martin J. Mackowski, Akhil Sheth
Client Alert / Newsletter
Illumina's $1.2B Buyout Dies Amid FTC 'Monopolist' Accusation Endpoints News (January 3, 2020)
In the News
Major Antitrust Developments To Watch In 2020 Law360 (January 1, 2020)
In the News

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with more than 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, DC, New York, Los Angeles, San Francisco, Orange County, London, and Brussels.

View Desktop Site | Mobile Sitemap

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2020
Attorney advertising - prior results do not guarantee a similar outcome.